, Les organes à risque évalués étaient : le sein controlatéral, le coeur, l'artère coronaire antérieure, les poumons, la thyroïde, le cordon médullaire, la tête humérale et le plexus brachial homolatéral

M. Overgaard, Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant Chemotherapy, N. Engl. J. Med, vol.337, pp.949-955, 1997.

M. Overgaard, Postoperative radiotherapy in high-risk postmenopausal breastcancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial, The Lancet, vol.353, pp.1641-1648, 1999.

, Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials, The Lancet, vol.378, pp.1707-1716, 2011.

, Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials, The Lancet, vol.383, pp.2127-2135, 2014.

, Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials, The Lancet, vol.366, pp.2087-2106, 2005.

H. Bartelink, Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 Trial, J. Clin. Oncol, vol.25, pp.3259-3265, 2007.

A. Lucci, Surgical Complications Associated With Sentinel Lymph Node Dissection (SLND) Plus Axillary Lymph Node Dissection Compared With SLND Alone in the American College of Surgeons Oncology Group Trial Z0011, J. Clin. Oncol, vol.25, pp.3657-3663, 2007.

A. E. Giuliano, Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial, JAMA, vol.318, p.918, 2017.

V. Galimberti, Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, Lancet Oncol, vol.19, pp.1385-1393, 2018.

M. Donker, Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial, Lancet Oncol, vol.15, pp.1303-1310, 2014.

P. Poortmans, Fifteen-year results of the randomised EORTC trial 22922/10925 investigating internal mammary and medial supraclavicular (IM-MS) lymph node irradiation in stage I-III breast cancer, J. Clin. Oncol, vol.36, pp.504-504, 2018.

T. J. Whelan, Regional Nodal Irradiation in Early-Stage Breast Cancer, N. Engl. J. Med, vol.373, pp.307-316, 2015.

S. Rivera, Radiothérapie axillaire prophylactique des cancers du sein

, Cancer/Radiothérapie, vol.19, pp.253-260, 2015.

, The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial, Lancet Oncol, vol.9, pp.331-341, 2008.

, The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial, The Lancet, vol.371, pp.1098-1107, 2008.

T. J. Whelan, Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer, N. Engl. J. Med, vol.362, pp.513-520, 2010.

, Cancer du sein infiltrant non métastatique. Questions d'actualité. Rapport intégral.Coll. Avis & Recommandations, Juillet, 2012.

R. Jagsi, Hypofractionated radiotherapy after mastectomy: a new frontier, Lancet Oncol, 2019.

L. J. Peters, Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02, J. Clin. Oncol, vol.28, pp.2996-3001, 2010.

A. Fairchild, Do results of the EORTC dummy run predict quality of radiotherapy delivered within multicentre clinical trials?, Eur. J. Cancer, vol.48, pp.3232-3239, 2012.

R. Del-campo and E. , Assessment of the novel online delineation workshop dummy run approach using FALCON within a European multicentre trial in cervical cancer (RAIDs)

, Radiother. Oncol, vol.124, pp.130-138, 2017.

T. Schimek-jasch, A teaching intervention in a contouring dummy run improved target volume delineation in locally advanced non-small cell lung cancer: Reducing the interobserver variability in multicentre clinical studies, Strahlenther. Onkol, vol.191, pp.525-533, 2015.

E. Musat, Dummy run and conformity indices in the ongoing EORTC low-grade glioma trial 22033-26033: First evaluation of quality of radiotherapy planning, Radiother. Oncol, vol.95, pp.218-224, 2010.

E. Chung, Dummy Run of Quality Assurance Program before Prospective Study of Hippocampus-Sparing Whole-Brain Radiotherapy (HS-WBRT) and Simultaneous Integrated Boost (SIB) for Multiple Brain Metastases from Non-Small Cell Lung Cancer: Korean Radiation Oncology Group (KROG) 17-06 Study, Cancer Res. Treat, 2018.

Y. Chung, Dummy Run of Quality Assurance Program in a Phase 3 Randomized Trial Investigating the Role of Internal Mammary Lymph Node Irradiation in Breast Cancer Patients: Korean Radiation Oncology Group 08-06 Study, Int. J. Radiat. Oncol, vol.91, pp.419-426, 2015.

A. Fairchild, Quality assurance for the EORTC 22071-26071 study: dummy run prospective analysis, Radiat. Oncol, vol.9, 2014.

C. Kirisits, Quality assurance in MR image guided adaptive brachytherapy for cervical cancer: Final results of the EMBRACE study dummy run, Radiother. Oncol, vol.117, pp.548-554, 2015.

O. Matzinger, Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: Dummy run and individual case review, Radiother. Oncol, vol.90, pp.285-290, 2009.

M. Coskun, Quality assurance of radiotherapy in the ongoing EORTC 22042-26042 trial for atypical and malignant meningioma: results from the dummy runs and prospective individual case Reviews, Radiat. Oncol, vol.8, p.23, 2013.

P. A. Fenton, Quality assurance of the EORTC 22043-30041 trial in post-operative radiotherapy in prostate cancer: Results of the Dummy Run procedure, Radiother. Oncol, vol.107, pp.346-351, 2013.

E. Versteijne, Quality assurance of the PREOPANC trial (2012-003181-40) for preoperative radiochemotherapy in pancreatic cancer: The dummy run, Strahlenther. Onkol, vol.193, pp.630-638, 2017.

M. Aoki, A. Yorozu, and T. Dokiya, Results of a dummy run of postimplant dosimetry between multi-institutional centers in prostate brachytherapy with 125I seeds, Jpn. J. Radiol, vol.27, pp.410-415, 2009.

J. G. Eriksen, Four years with FALCON -An ESTRO educational project: Achievements and perspectives, Radiother. Oncol, vol.112, pp.145-149, 2014.

B. De-bari, Short interactive workshops reduce variability in contouring treatment volumes for spine stereotactic body radiation therapy: Experience with the ESTRO FALCON programme and EduCase TM training tool, Radiother. Oncol, vol.127, pp.150-153, 2018.

B. V. Offersen, ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, Radiother. Oncol, vol.114, pp.3-10, 2015.

M. Feng, Development and Validation of a Heart Atlas to Study Cardiac Exposure to Radiation Following Treatment for Breast Cancer, Int. J. Radiat. Oncol, vol.79, pp.10-18, 2011.

F. Kong and ). Spring, Consideration of Dose Limits for Organs at Risk of Thoracic Radiotherapy: Atlas for Lung, Proximal Bronchial Tree, Esophagus, Spinal Cord, Ribs, and Brachial Plexus, Int. J. Radiat. Oncol, vol.81, pp.1442-1457, 2011.

M. H. Nielsen, Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: National guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group, Acta Oncol, vol.52, pp.703-710, 2013.

P. Pradat, Neuropathies post-radiques : un dommage collatéral chez les patients cancéreux long-survivants, Rev. Neurol, vol.168, pp.939-950, 2012.

S. Delanian and J. Lefaix, The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway, Radiother. Oncol, vol.73, pp.119-131, 2004.

R. Allozi, Tools for consensus analysis of experts' contours for radiotherapy structure definitions, Radiother. Oncol, vol.97, pp.572-578, 2010.

G. C. Mattiucci, Automatic delineation for replanning in nasopharynx radiotherapy: What is the agreement among experts to be considered as benchmark?, Acta Oncol, vol.52, pp.1417-1422, 2013.

D. C. Weber, Outcome impact and cost-effectiveness of quality assurance for radiotherapy planned for the EORTC 22071-24071 prospective study for head and neck cancer, Radiother. Oncol, vol.111, pp.393-399, 2014.

T. Budiharto, Profile of European radiotherapy departments contributing to the EORTC Radiation Oncology Group (ROG) in the 21st century, Radiother. Oncol, vol.88, pp.403-410, 2008.

. Vii-annexes-:-liste, . Des, and . Acosog, American College of Surgeons Oncology Group DBCCG: Danish Breast Cancer Cooperative Groupe CTVp_breast : Clinical Target Volume du sein CTVn_interpec : Volume cible anatomo-clinique de l'aire ganglionnaire inter pectorale CTVn_CMI : Volume cible anatomo-clinique de la chaine mammaire interne CTVn_L1 : Volume cible anatomo

, CTVn_L2 : Volume cible anatomo-clinique de l'aire ganglionnaire n°2

, CTVn_L3 : Volume cible anatomo-clinique de l'aire ganglionnaire n°3

, CTVn_L4 : Volume cible anatomo-clinique de l'aire ganglionnaire n°4 EBCTCG: Early Breast Cancer Trialist Collaborative Group EORTC: European Organisation for Research and Treatement of Cancer IBCSG: International Breast Cancer Study Group IMRT: Intensity Modulated RadioTherapy INCa: Institut National du Cancer FALCON: Fellowship in Anatomic deLineation and CONtouring